WANDA BEARING
920002
CG MED EQUIP.
838810
SUZHOUBEARING
430418
4
COCYBER
835207
5
Guangdong Create Century Intelligent Equipment Group Corporation
300083
US Stock MarketDetailed Quotes
GALT Galectin Therapeutics
- 1.470
- +0.010+0.68%
Close Feb 25 16:00 ET
- 1.422
- -0.048-3.27%
Pre 08:15 ET
92.26MMarket Cap-2.01P/E (TTM)
1.490High1.425Low158.51KVolume1.460Open1.460Pre Close231.61KTurnover0.36%Turnover RatioLossP/E (Static)62.76MShares4.26852wk High-0.97P/B64.54MFloat Cap0.72652wk Low--Dividend TTM43.90MShs Float38.280Historical High--Div YieldTTM4.45%Amplitude0.300Historical Low1.461Avg Price1Lot Size
Galectin Therapeutics News
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update
Galectin Therapeutics | 10-Q: Q3 2024 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update
Galectin Therapeutics | 10-Q: Q2 2024 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update
Galectin Therapeutics | 10-Q: Q1 2024 Earnings Report
Galectin Therapeutics | 10-K: FY2023 Annual Report
Galectin Therapeutics | 8-K/A: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
Galectin Therapeutics | 10-Q: Q3 2023 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2023 and Provides Business Update
Galectin Therapeutics | 10-Q: Q2 2023 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2023 and Provides Business Update
Galectin Therapeutics | 10-Q: Q1 2023 Earnings Report
Galectin Therapeutics | 10-K: FY2022 Annual Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Business Update
Galectin Therapeutics | 10-Q: Q3 2022 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2022 and Provides Business Update
Galectin Therapeutics | 10-Q: Q2 2022 Earnings Report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025